GCH1 and colorectal carcinoma: In conclusion, this study revealed that GCH1/BH4 metabolism acts to inhibit erastin-induced ferroptosis by restraining NCOA4-mediated ferritinophagy, providing a potential antitumor target for amplifying the ferroptotic activity of erastin induction in CRC.